Atherosclerosis occurs in the subendothelial space (intima) of medium-sized arteries at regions of disturbed blood flow and is triggered by an interplay between endothelial dysfunction and subendothelial lipoprotein retention. Over time, this process stimulates a nonresolving inflammatory response that can cause intimal destruction, arterial thrombosis, and end-organ ischemia. Recent advances highlight important cell biological atherogenic processes, including mechanotransduction and inflammatory processes in endothelial cells, origins and contributions of lesional macrophages, and origins and phenotypic switching of lesional smooth muscle cells. These advances illustrate how in-depth mechanistic knowledge of the cellular pathobiology of at...
Atherosclerosis is an inflammatory disease resulting in the hardening and thickening of the wall of ...
Atherosclerosis is a multifocal, smoldering, immunoinflammatory disease of medium-sized and large ar...
The regulatory mechanisms of the inflammatory process in the atherosclerotic plaque are still not cl...
In the development of atherosclerotic lesions, three basic processes occur: 1) invasion of the arter...
Atherosclerosis is a chronic, inflammatory disease of the arterial wall that underlies many of the c...
Atherosclerosis is a chronic, inflammatory disease of the arterial wall that underlies many of the c...
Atherosclerosis is the principal cause of cardiovascular disease that continues to be a substantial ...
Atherosclerosis is an inflammatory disease of the large arteries that is the major cause of cardiova...
The traditional view of atherosclerosis as a pathological lipid deposition within the artery wall ha...
During the development of an atherosclerotic plaque, mononuclear leukocytes infiltrate the artery wa...
is characterized with plaque formation in large and medium-sized blood vessels. The stiffened and na...
Atherosclerosis is a chronic and progressive inflammatory disease of the arteries initiated by the f...
Cardiovascular disease remains a leading cause of mortality in the United States despite the use of ...
Current therapies for patients with atherosclerosis are targeted primarily on reducing blood cholest...
BACKGROUND: Atherosclerosis is a leading cause of vascular disease worldwide. During the past severa...
Atherosclerosis is an inflammatory disease resulting in the hardening and thickening of the wall of ...
Atherosclerosis is a multifocal, smoldering, immunoinflammatory disease of medium-sized and large ar...
The regulatory mechanisms of the inflammatory process in the atherosclerotic plaque are still not cl...
In the development of atherosclerotic lesions, three basic processes occur: 1) invasion of the arter...
Atherosclerosis is a chronic, inflammatory disease of the arterial wall that underlies many of the c...
Atherosclerosis is a chronic, inflammatory disease of the arterial wall that underlies many of the c...
Atherosclerosis is the principal cause of cardiovascular disease that continues to be a substantial ...
Atherosclerosis is an inflammatory disease of the large arteries that is the major cause of cardiova...
The traditional view of atherosclerosis as a pathological lipid deposition within the artery wall ha...
During the development of an atherosclerotic plaque, mononuclear leukocytes infiltrate the artery wa...
is characterized with plaque formation in large and medium-sized blood vessels. The stiffened and na...
Atherosclerosis is a chronic and progressive inflammatory disease of the arteries initiated by the f...
Cardiovascular disease remains a leading cause of mortality in the United States despite the use of ...
Current therapies for patients with atherosclerosis are targeted primarily on reducing blood cholest...
BACKGROUND: Atherosclerosis is a leading cause of vascular disease worldwide. During the past severa...
Atherosclerosis is an inflammatory disease resulting in the hardening and thickening of the wall of ...
Atherosclerosis is a multifocal, smoldering, immunoinflammatory disease of medium-sized and large ar...
The regulatory mechanisms of the inflammatory process in the atherosclerotic plaque are still not cl...